Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1

Nature Cell Biology

Volumn 2, Issue 5, 2000, Pages 261-267

  Xu, Yan ^a   Zhu, Kui ^a   Hong, Guiying ^a   Wu, Weihua ^a   Baudhuin, Linnea M ^a   Xiao, Yi Jin ^a   Damron, Derek S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; SPHINGOSYLPHOSPHORYLCHOLINE;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CELL ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; MITOSIS INHIBITION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

CALCIUM; CLONING, MOLECULAR; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; INDICATORS AND REAGENTS; KIDNEY; LIGANDS; LUMINESCENT PROTEINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLCHOLINE; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS; SPHINGOSINE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033772419     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35010529     Document Type: Article

References (50)

1. Sphingolipid metabolites: Members of a new class of lipid s messengers
2. Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines
3. Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions
4. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes
5. Lysophospholipids activate ovarian and breast cancer cells
6. Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphoryl-choline
7. Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signalling cascade in rat neonatal cardiac myocytes
8. Modulation of smooth muscle contraction by sphingosylphosphorylcholine
9. A new wound healing agent - Sphingosylphosphorylcholine
10. Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p 125 FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p 21 rho in the signalling pathway
11. Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3 T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein
12. 2- mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL 60 leukaemia cells
13. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes
14. Effect of lysophospholipids on signalling in the human Jurkat T cell line
15. Sphingosylphosphocholine, a signalling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1
16. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes
17. Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro
18. Ventricular Zone Gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
19. Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids
20. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
21. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
22. EDG 6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue
23. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5
24. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H 218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins
25. EDG 3 is a functional receptor specific for sphingosine 1 -phosphate and sphingosylphosphorylcholine with AGR 16
26. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition
27. 2+ system by sphingosine 1 -phosphate in CHO cells transfected with Edg-3, a putative lipid receptor
28. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H 218
29. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1
30. Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine
31. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukaemia HL-60 cells and human neutrophils
32. Identification of human OGR 1, a novel G protein-coupled receptor that maps to chromosome 14
33. 2+ mobilization in human platelet
34. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
35. G protein-coupled receptors
36. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation
37. Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes
38. 2+ dependent purinergic regulation of p 42 and p 44 MAP kinases in astroglial cultured cells
39. MAP kinase pathways
40. Okadaic acid activates p 42 mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: Contrast with phorbol 12-myristate 13-acetate
41. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells
42. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells
43. Lysosphingolipids and mitochondrial function. II. Deleterious effects of sphingosylphosphorylcholine
44. Sphingosylphosphorylcholine in Niemann-Pick disease brain: Accumulation in type A but not in type B
45. Abnormal expression of sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency?
46. Metabolism and neurite promoting effect of xogenous sphingosylphosphocholine in cultured routine neuroblastoma cells
47. Calcium mobilisation in ovarian cancer by lysophospholipids
48. 2+ oscillations in canine pulmonary artery smooth muscle cells
49. 2+ indicators with greatly improved fluorescence properties